US equities
|
MU
$904.83
▼-0.01%
NVDA
$216.58
▼-0.23%
SPCX
$147.09
▼-0.59%
TSLA
$375.36
▲+1.98%
META
$689.45
▼-2.27%
SNDK
$1,371.80
▲+0.05%
AAPL
$339.08
▼-1.12%
INTC
$92.24
▲+0.23%
MU
$904.83
▼-0.01%
NVDA
$216.58
▼-0.23%
SPCX
$147.09
▼-0.59%
TSLA
$375.36
▲+1.98%
META
$689.45
▼-2.27%
SNDK
$1,371.80
▲+0.05%
AAPL
$339.08
▼-1.12%
INTC
$92.24
▲+0.23%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Akili Interactive Labs, Inc.
The Journal Lupus Publishes Investigator-Initiated Study Results Demonstrating Improved Executive Function in Patients with Systemic Lupus Erythematosus Following Use of Akili’s AKL-T01 Product Candidate
July 14, 2022
From
Akili Interactive Labs, Inc.
Via
Business Wire
PLOS ONE Publishes Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional Functioning
February 17, 2022
From
Akili Interactive Labs, Inc.
Via
Business Wire
Tickers
DNAA